Susan E. Quaggin
Director of the Feinberg Cardiovascular Research Institute, Chief of the Division of Nephrlogy/Hypertension, and the Charles Horace Mayo Professor of MedicineSusan E. Quaggin, Director of the Feinberg Cardiovascular and Renal Research Institute, Chief of the Division of Nephrology/Hypertension, and the Charles Horace Mayo Professor of Medicine, has been named as one of the 13th recipients of the Dorothy Ann and Clarence L. Ver Steeg Distinguished Research Fellowship Award.
Throughout the past two decades, Quaggin’s research has contributed to the increased understanding of common kidney and vascular diseases. In 1997, her lab discovered a gene that is vital for the development of healthy hearts, kidneys, and lungs. The gene is required for formation of specialized cells in the kidney that help form the filtration barrier responsible for removing excess fluid and waste from the blood, and prevent the loss of things the body needs, like protein.
A graduate of the Faculty of Medicine at the University of Toronto, Quaggin received her specialty degree in internal medicine in 1992. She completed subspecialty training in nephrology at the University of Toronto and did a post-doctoral fellowship at Yale University, where she studied the genetic basis of kidney development. In 1997, she returned to Toronto for a second post-doctoral fellowship in complex mouse genetics.
Throughout her career, Quaggin has chaired many international research meetings and review panels and was elected to the American Society for Clinical Investigation in 2006 and the Association of American Physicians in 2013. She is a member of the External Scientific Panel of Astra Zeneca and CSO of Mannin Research. Currently she serves as a councilor and future President of the American Society of Nephrology and Chair of the PBKD NIH Study Section.